Form 4: Zymeworks EVP Acquires Shares Under ESPP

Zymeworks Inc. reports that Hollywood Mark, EVP & Chief Operating Officer, acquired 939 shares of common stock through the company's Employee Stock Purchase Plan on July 6, 2026.

Summary

• Hollywood Mark, Executive Vice President and Chief Operating Officer of Zymeworks Inc., acquired 939 shares of common stock.
• The acquisition occurred on July 6, 2026, under the Issuer's Employee Stock Purchase Plan (ESPP).
• The ESPP purchase period was from January 1, 2026, to June 30, 2026.
• The purchase price was $22.22 per share, reflecting a 15% discount to the closing price on June 30, 2026.
• Following this transaction, Hollywood Mark beneficially owns 133,852 shares of Zymeworks Inc. common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider stock acquisition under an established employee plan rather than a significant strategic event.

Positives

• Executive leadership participation in employee stock purchase plans indicates confidence in the company's future.
• The acquisition was made at a discounted price, offering a financial benefit to the executive.
• The transaction was executed under a pre-established ESPP, suggesting a planned and structured approach to equity participation.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing, which is a Form 4 detailing a stock transaction.

Industry Context

StockSavvy.ai notes that insider transactions, particularly under employee stock purchase plans, are common in the biotechnology sector as companies aim to retain and incentivize key personnel. The discount offered through the ESPP is a standard practice to encourage employee investment.

Stakeholder Impact

• Shareholders: The acquisition by a key executive may be viewed positively as a sign of commitment, but the impact on share price is likely minimal given the nature of the transaction.

Key Dates

Keywords

Zymeworks Inc., ZYME, Form 4, Stock Purchase, Employee Stock Purchase Plan, ESPP, Insider Transaction, Executive Compensation, Beneficial Ownership